Koga Hiroyuki, Ochi Takanori, Okawada Manabu, Doi Takashi, Lane Geoffrey J, Yamataka Atsuyuki
Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo Japan.
Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo Japan.
J Pediatr Surg. 2014 Dec;49(12):1815-7. doi: 10.1016/j.jpedsurg.2014.09.028. Epub 2014 Nov 13.
All reports comparing laparoscopy-assisted anorectoplasty (LAARP) with posterior sagittal anorectoplasty (PSARP) in male high-type imperforate anus include a mix of recto-vesical, recto-prostatic, recto-bulbar, and absent fistula cases without focusing on recto-bulbar fistula (RBF), the most challenging type to treat laparoscopically. We compared LAARP with PSARP for treating only RBF.
We used our fecal continence evaluation questionnaire (FCE; maximum score=10), scoring of magnetic resonance imaging (MRI) findings (MRI scores), and the angle between the rectum and the anal canal (RAA) to assess 20 RBF cases (LAARP=12, PSARP=8) treated from 2000 to 2013 prospectively.
Mean ages at surgery, MRI scores, mean RAA, and duration of raised C-reactive protein (6.6 vs. 6.7days; p=NS) were similar. In all cases, postoperative MRI showed no residual fistula and normal urination. LAARP had consistently higher FCE (7.9 vs. 7.8 at 3years; 8.6 vs. 8.3 at 5years; 8.9 vs 8.6 at 7years; p=NS, respectively), less wound infections (0 vs. 37.5%; p<0.05), higher incidence of rectal mucosal prolapse (50.0 vs. 0%; p<0.05), and required less analgesia (p<0.05).
Although LAARP and PSARP are comparable for treating RBF, LAARP is associated with less wound infections and higher incidence of rectal mucosal prolapse.
所有比较腹腔镜辅助肛门直肠成形术(LAARP)与后矢状位肛门直肠成形术(PSARP)治疗男性高位无肛的报告均包含直肠膀胱瘘、直肠前列腺瘘、直肠球部瘘及无瘘病例的混合情况,未聚焦于直肠球部瘘(RBF),而这是腹腔镜治疗最具挑战性的类型。我们比较了LAARP与PSARP仅用于治疗RBF的效果。
我们使用粪便控便评估问卷(FCE;最高分=10)、磁共振成像(MRI)结果评分(MRI评分)以及直肠与肛管之间的角度(RAA),对2000年至2013年期间前瞻性治疗的20例RBF病例(LAARP组12例,PSARP组8例)进行评估。
手术时的平均年龄、MRI评分、平均RAA以及C反应蛋白升高的持续时间(6.6天对6.7天;p=无显著差异)相似。所有病例术后MRI均显示无残留瘘且排尿正常。LAARP的FCE评分始终较高(3年时为7.9对7.8;5年时为8.6对8.3;7年时为8.9对8.6;p均为无显著差异),伤口感染较少(0对37.5%;p<0.05),直肠黏膜脱垂发生率较高(50.0%对0%;p<0.05),且所需镇痛较少(p<0.05)。
尽管LAARP和PSARP在治疗RBF方面效果相当,但LAARP与较少的伤口感染和较高的直肠黏膜脱垂发生率相关。